MiddleGround Capital on the art of the automotive deal

Linden Capital Partners on why healthcare CVs are gaining traction

McDermott on preparing for exit in a selective M&A market

Taproot Capital on understanding the seeding opportunity for spin-outs

Simpson Thacher & Bartlett on how buyside expansion fuels dealflow

W Capital Partners on why secondaries is now core to PE portfolio management

Fried Frank on the next step for CVs

Dawson Partners on predicting a $300bn year for secondaries